期刊文献+

GBV-C/HGV在血清学非甲~戊型急性肝炎发生中的作用

Influence of GBV-C/HGV on the etiology of acute non A~E hepatitis
下载PDF
导出
摘要 探讨GBV-C/HGV在血清学非甲~戊型急性肝炎发生中的作用及临床意义.采用免疫组化方法对56例血清学非甲~戊型急性肝炎患者肝组织标本进行GBV-C/HGV NS5抗原的检测,结合临床资料进行分析.血清学非甲~戊型急性肝炎肝组织中GBV-C/HGV NS5抗原检出率为53.6%,主要是以和HBV/HCV重叠感染的形式存在,重叠感染组的ALT升高和HBV/HCV感染组差异无显著意义.单纯GBV-C/HGV感染占16.1%,所引起的血清ALT升高明显低于HBV/HCV感染,而与病原不明病例差异无显著意义.GBV-C/HGV可能没有致病性或者有弱致病性,不是血清学非甲~戊型急性肝炎的主要致病因子. To investigate the role of GB virus C/hepatitis G virus (GBV -C/HGV) on the etiology of acute non A -E hepatitis. Liver biopsy from 56 patients with acute non A - E hepatitis were detected for GBV - C/HGV non - structure 5 antigen ( NS5 Ag) by immunohistochemistry. The pathological results and the clinical data were analyzed. In acute non A - E hepatitis, the total positive rate of GBV - C/HGV NS5 Ag in liver tissues was 53.6%. The majority were coinfected with HBV or HCV. The liver function test (ALT) in acute hepatitis B or C was similar in patients coinfected and in those not coinfected with GBV - C/HGV. Only 16. 1% were infected with GBV - C/HGV alone. The ALT were significantly lower in the patients with GBV - C/HGV infected alone than those with HBV or HCV co infected, but similar to those in acute hepatitis of unknown etiology. The pathogenicity of GBV - C/HGV is doubtful. GBV - C/HGV may not be one of the main pathogenic agents of acute hepatitis.
出处 《临床肝胆病杂志》 CAS 2007年第2期98-99,共2页 Journal of Clinical Hepatology
关键词 庚型肝炎病毒 免疫组织化学 致病性 GB virus C/hepatitis G virus immunohistochemistry pathogenicity
  • 相关文献

参考文献2

二级参考文献34

  • 1[1]Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Comm 1997; 241:92-97
  • 2[2]Mushahwar IS, Erker JC, Muerhoff AS, Leary TP, Simons JN,Birkenmeyer LG, Chalmers ML, Piolt-Matias TJ, Dexai SM. Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci USA 1999; 96:3177-3182
  • 3[3]Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H,Miyakawa Y, Mayumi M. Molecular cloning and characterisation of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998; 10:1-16
  • 4[4]Simons JN, Pilot-Mathias TJ, Leary TP. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci 1995; 92:3401-3405
  • 5[5]Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM,Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM.Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998; 352:191-194
  • 6[6]Wolff C, Diekmann A, Boomgaarden M, Korner MM, Kleesiek K. Viremia and excretion of TT virus in immunosuppressed heart transplant recipients and in immunocompetent individuals.Transplantation 2000; 69:351-356
  • 7[7]Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T,Krom R, Wiesner R. TT-virus infection in north American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998; 28:839-842
  • 8[8]Desai SM, Muerhoff AS, Leary TP, Erker JC, Simons JN, Chalmers ML, Birkenmeyer LG, Pilot-Matias TJ, Mushahwar IK. Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infec Disease 1999;179:1242-1244
  • 9[9]Gad A, Tanaka E, Orii K, Kafumi T, Serwah AE, El-Sherif A,Nooman Z, Kiyosawa K. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt. J Med Virol 2000; 60:177-181
  • 10[10]Tanaka H, Okamoto H, Luengrojanakul P, Chainuvata T, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Infection with an unenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis in hepatitis patients and healthy blood donors in Thailand. J Med Virol 1998; 56:234-238

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部